News

TrueDXPSA test will enable doctors to rapidly determine the PSA level in a patient. True Diagnostics president and CEO Jerry Lee said, "With our TrueDX™PSA, the Company provides

The new device technology facilitates delivery of drugs and biologics into the body through the nasal route. Mystic president and CEO Timothy Sullivan said nasal vaccines will expand

The $30m expansion is expected to support the manufacturing projects, improve infrastructure at the site for future extension. FCS business director David DeCuir said, "This expansion comes shortly

Available in both capsule and powder formulations, the product made from powdered leaves of Moringa oleifera tree contains vitamin A, B1, B3, B12, iron, magnesium, potassium, amino acids,

The new patent (US 8,367,586), which the company claims is the first for its antibody platform, covers the composition of MorphoSys’s Ylanthia that comprises more than 100 billion

As part of the project, the company considers expanding clean room molding and assembly capacity in addition to launching art logistics system designed to control the flow of

The application was supported by data from Phase III study of trametinib monotherapy compared to dacarbazine monotherapy conducted in metastatic melanoma patients with BRAF V600 mutation. Data from

The 16,000ft² facility is the fourth center of excellence of Ansell while the other three include Malaysia, Mexico and North America-based centers. Ansell managing director and CEO Magnus

Apogenix also announced the commencement of Apocept Phase I trial in MDS patients in Germany. Endpoints of the open-label study include efficacy (improvement of erythropoiesis), safety, and tolerability